Skip to main content

. 1946 May;25(3):337–346. doi: 10.1172/JCI101714

STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. II. THE INHIBITION OF STREPTOCOCCAL FIBRINOLYSIS BY ANTIFIBRINOLYSIN AND ANTIPROTEASE ^¹

Melvin H Kaplan ¹

PMCID: PMC435570 PMID: 16695324

337

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

Boisvert P. L. THE STREPTOCOCCAL ANTIFIBRINOLYSIN TEST IN CLINICAL USE. J Clin Invest. 1940 Jan;19(1):65–74. doi: 10.1172/JCI101123. [DOI] [PMC free article] [PubMed] [Google Scholar]
Cohn E. J., Oncley J. L., Strong L. E., Hughes W. L., Armstrong S. H. CHEMICAL, CLINICAL, AND IMMUNOLOGICAL STUDIES ON THE PRODUCTS OF HUMAN PLASMA FRACTIONATION. I. THE CHARACTERIZATION OF THE PROTEIN FRACTIONS OF HUMAN PLASMA. J Clin Invest. 1944 Jul;23(4):417–432. doi: 10.1172/JCI101508. [DOI] [PMC free article] [PubMed] [Google Scholar]
Kaplan M. H. STUDIES OF STREPTOCOCCAL FIBRINOLYSIS. I. THE DISSIMILARITY OF SERUM PROTEASE AND TRYPSIN AS INDICATED BY THE SEPARATE SPECIFICITIES OF THEIR KINASES, FIBRINOLYSIN AND ENTEROKINASE. J Clin Invest. 1946 May;25(3):331–336. doi: 10.1172/JCI101713. [DOI] [PMC free article] [PubMed] [Google Scholar]
Le Mar J. D., Gunderson M. F. Studies on Streptococcal Fibrinolysis. J Bacteriol. 1940 Jun;39(6):717–725. doi: 10.1128/jb.39.6.717-725.1940. [DOI] [PMC free article] [PubMed] [Google Scholar]
Mirsky I. A. INHIBITION OF beta HEMOLYTIC STREPTOCOCCI FIBRINOLYSIN BY TRYPSIN INHIBITOR (ANTIPROTEASE). Science. 1944 Sep 1;100(2592):198–200. doi: 10.1126/science.100.2592.198. [DOI] [PubMed] [Google Scholar]
Myers W. K., Keefer C. S., Holmes W. F. THE RESISTANCE TO FIBRINOLYTIC ACTIVITY OF THE HEMOLYTIC STREPTOCOCCUS WITH SPECIAL REFERENCE TO PATIENTS WITH RHEUMATIC FEVER AND RHEUMATOID (ATROPHIC) ARTHRITIS. J Clin Invest. 1935 Jan;14(1):119–123. doi: 10.1172/JCI100646. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tagnon H. J., Davidson C. S., Taylor F. H. STUDIES ON BLOOD COAGULATION: A PROTEOLYTIC ENZYME PREPARED FROM CALCIUM AND PLATELET FREE NORMAL HUMAN BLOOD PLASMA. J Clin Invest. 1942 Sep;21(5):525–531. doi: 10.1172/JCI101329. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tillett W. S., Edwards L. B., Garner R. L. FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. THE DEVELOPMENT OF RESISTANCE TO FIBRINOLYSIS FOLLOWING ACUTE HEMOLYTIC STREPTOCOCCUS INFECTIONS. J Clin Invest. 1934 Jan;13(1):47–78. doi: 10.1172/JCI100579. [DOI] [PMC free article] [PubMed] [Google Scholar]
Tillett W. S. THE FIBRINOLYTIC ACTIVITY OF HEMOLYTIC STREPTOCOCCI. Bacteriol Rev. 1938 Dec;2(2):161–216. doi: 10.1128/br.2.2.161-216.1938. [DOI] [PMC free article] [PubMed] [Google Scholar]
Waaler E. DEVELOPMENT OF ANTIFIBRINOLYTIC PROPERTIES IN BLOOD OF PATIENTS WITH RHEUMATIC FEVER, CHRONIC INFECTIVE ARTHRITIS AND BACTERIAL ENDOCARDITIS. J Clin Invest. 1937 Jan;16(1):145–153. doi: 10.1172/JCI100832. [DOI] [PMC free article] [PubMed] [Google Scholar]

ACTIONS

RESOURCES